Report Overview: The Global Deoxyribonucleic Acid (DNA) Vaccines Market achieved a valuation of $4.28 Billion in 2022 and is anticipated to exceed $7.41 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 7.1% during the forecast period from 2024 to 2032. Key Market Players: Inovio Biomedical Corp, Merck & Co., Mitsubishi Tanabe, Dendreon Corporation,...